Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

AML MRD testing with flow cytometry

The Flow Cytometry device, shown as equipment
Illustration: The Flow Cytometry device, shown as equipment

Short answer

AML MRD flow cytometry looks for small populations of abnormal myeloid cells after treatment and helps the haematology team assess response and plan follow-up care.

This answers one question. It is not a diagnosis and does not replace an assessment by a licensed doctor.

At a glance

MRD stands for
Measurable residual disease
Common specimen
Bone marrow
Interpret with
Treatment timing, sample quality and other leukaemia findings

The result in context

MRD means measurable residual disease. The test is more sensitive than simply viewing cells under a microscope, but it is one part of response assessment and does not make a treatment decision by itself.

How flow cytometry finds residual disease

The laboratory passes cells individually through a laser and records patterns of markers on and within them. Specialists compare these patterns with those expected in healthy developing blood cells and with the abnormal pattern identified in the leukaemia.

A detected result means cells with a concerning pattern were found in the tested sample. A not-detected result means the laboratory did not identify such cells above its reporting limit; it cannot exclude every remaining leukaemia cell. Sample quality and timing affect interpretation.

What happens around the test

MRD flow cytometry usually uses bone marrow because AML develops there, although blood may be informative in selected circumstances. Before sampling, tell the team about blood-thinning medicines, bleeding problems, allergies and previous difficulty with marrow procedures.

Review the report with the haematology team rather than comparing a single word across laboratories. Ask whether the sample was adequate, what method and reporting limit were used, how the finding compares with earlier samples, and whether molecular testing adds useful information.

When symptoms need a prompt response

After a bone marrow sample, contact the procedure team for increasing redness, swelling, discharge, persistent bleeding or worsening pain at the site. Follow the dressing and activity advice supplied by the clinic.

During or after AML treatment, fever, shaking chills, uncontrolled bleeding, severe breathlessness, chest pain, confusion or sudden deterioration require urgent medical attention according to your haematology service's emergency instructions. Do not wait for an MRD appointment to report these problems.

Making sense of your report

Useful questions include: At what treatment point was this sample taken? Was MRD detected, and how certain is the classification? Was the specimen good enough to assess? Does the result change my current plan? When will testing be repeated, and will the same technique be used?

Questions people ask

Does MRD not detected mean AML is permanently gone?

No. It means the chosen method did not find abnormal cells above its reporting limit in that sample. Continued clinical and laboratory follow-up remains necessary.

Is an MRD-detected result the same as a visible relapse?

Not necessarily. MRD can identify an abnormal cell population before leukaemia is apparent by routine cell counting. The team interprets it alongside marrow appearance, blood counts and other tests.

Why might repeat samples be requested?

Results at different treatment points show how the abnormal cell population changes over time and can support decisions about the next phase of care.

Related

Related reading

Keep reading

More on this

Cancer care in the UAE

Hospitals & Medical Centers in Abu Dhabi

Most UAE cancer care is delivered inside hospital services rather than by standalone oncology clinics, so these are licensed hospitals & medical centers listed in Abu Dhabi. Confirm the specific cancer service exists before you travel, and know that asking for a second opinion is routine.

City
  • Ahalia Hospital Musaffah Building - Musaffah - Musaffah Industrial - Abu Dhabi - United Arab Emirates

    Accepts: Daman, Thiqa, AXA, Cigna +26 more

  • Al Ruwais Industrial City - Abu Dhabi - United Arab Emirates

    Accepts: Daman, Thiqa, AXA, Cigna +30 more

  • Abu Dhabi, Abu Dhabi

    Accepts: Daman, Thiqa, AXA, Cigna +30 more

Second opinions are routine in cancer care and asking for one does not affect your treatment. How to arrange a second opinion in the UAE.

Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.

A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.

Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.